US OptionsDetailed Quotes

CGON241220P17500

Watchlist

0.00
0.000.00%

15min DelayClose Nov 29 09:30 ET

0.00High0.00Low

CG Oncology Stock Discussion

Teo knows

Nov 25 08:57

$CG Oncology (CGON.US)$ fly

Meltyy

May 22 02:52

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Meltyy

Apr 18 03:34

🎯 Ph 3 readouts in Q2 2024...

$Travere Therapeutic (TVTX.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$United Therapeutics (UTHR.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3
$Insmed (INSM.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Jaguar Health (JAGX.US)$ Phas...

Meltyy

Apr 1 02:47

Biotech Stock Catalyst Watchlist

🎯 Ph 3 readouts in Q2 2024...
$Intra-Cellular Therapies (ITCI.US)$ Phase 3
$CG Oncology (CGON.US)$ Phase 3
$Hutchmed (China) (HCM.US)$ Phase 3
$Viracta Therapeutics (VIRX.US)$ Phase 3
$GlycoMimetics (GLYC.US)$ Phase 3
$Annexon (ANNX.US)$ Phase 3
$Lipocine (LPCN.US)$ Phase 3
$FibroGen (FGEN.US)$ Phase 3
$UroGen Pharma Ltd (URGN.US)$ Phase 3
$Lyra Therapeutics (LYRA.US)$ Phase 3
$Citius Pharmaceuticals (CTXR.US)$ Phase 3
$Marinus Pharmaceuticals (MRNS.US)$ Phase 3
$BioCardia (BCDA.US)$ Phase 3...

Moomoo AI

Jan 26 10:59

CG Oncology's successful IPO hints at a possible resurgence of investor interest in biotech stocks, despite the sector's recent underperformance. This strong debut is viewed as a positive indicator for the sector's future.

Biotech's First IPO of 2024 Popped 96%. Good Times Could Be Ahead for the Stocks. -- Barrons.com

Moomoo AI

Jan 25 14:11

The successful IPO of CG Oncology and its strong performance on debut indicates a revival in the market for initial public offerings, which could be a positive sign for other companies planning to go public.

CG Oncology IPO Rockets 85% in Sign of Pent-up Deal Demand

I love me

Jan 25 13:08

$CG Oncology (CGON.US)$ Fn incredible a brand new stock ipo that has amazing health and curing benefits and obviously needs needs stock to go up for future improvements and new medications THE SHIRTS ARE ALREADY HERE ILLEGALLY SHORTING COMPANY BOUGHT HUGE VOLUMES AND WILL CONTINUE TO SELL THEM AT A LIMIT AND BUY BACK AND SELL BACK RINSE AND REPEAT TILL PEOPLE ARE PISSWD AND LEAVE THEN THEY CAN DUMP THE COMPANY VALUE. STRAIGHT UP COC#SUCKERS

Moomoo AI

Jan 25 06:58

The successful pricing and increased size of CG Oncology's IPO indicates strong investor interest and a bullish sentiment towards the company. This could also signal a revival in the market for initial public offerings.

CG Oncology IPO Prices Above Range and Boosts Share Count in Bullish Move Ahead of Trading

No comment yet